Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter H Stone

Showing results (11-20 of 205) with videos related to

Pageof 21
Sort By:
Journal of the American College of Cardiology|August 13, 2011
Allopurinol a new anti-ischemic role for an old drugPeter H Stone
Cardiology Clinics|October 22, 2008
Ranolazine: new paradigm for management of myocardial ischemia, myocardial dysfunction, and arrhythmiasPeter H Stone
JACC. Cardiovascular Imaging|July 22, 2019
The Hazardous Longitudinal Heterogeneity of Plaques: A Complex Mountain Range, Not a Single VolcanoPeter H Stone
The New England Journal of Medicine|October 22, 2004
Triggering myocardial infarctionPeter H Stone
Journal of the American College of Cardiology|November 13, 2007
C-reactive protein to identify early risk for development of calcific aortic stenosis: right marker? Wrong time?Peter H Stone
European Heart Journal|April 22, 2019
Evaluation of individual plaque risk based on plaque anatomic and biomechanical characteristics: methodologies and clinical applications are approaching an inflection pointPeter H Stone
JACC. Cardiovascular Imaging|August 4, 2022
Progressive Understanding of Coronary Microvascular Disease and Vasomotor Dysfunction: Some Answers, More QuestionsPeter H Stone
Journal of the American College of Cardiology|July 10, 2003
Early glycoprotein IIb/IIIa inhibitors in patients with non-ST-segment elevation myocardial infarction: are we ready to open the floodgates?Peter H Stone, Yerem Yeghiazarians
Circulation|November 9, 2016
In-Stent Atherosclerosis at a Crossroads: Neoatherosclerosis … or Paleoatherosclerosis?Ioannis Andreou, Peter H Stone
Current Treatment Options in Cardiovascular Medicine|January 17, 2002
ST-Segment Elevation Myocardial InfarctionYerem Yeghiazarians, Peter H. Stone
Pageof 21

Showing results (11-20 of 205) with videos related to

Sort By:
Pageof 21
Journal of the American College of Cardiology|August 13, 2011
Allopurinol a new anti-ischemic role for an old drugPeter H Stone
Cardiology Clinics|October 22, 2008
Ranolazine: new paradigm for management of myocardial ischemia, myocardial dysfunction, and arrhythmiasPeter H Stone
JACC. Cardiovascular Imaging|July 22, 2019
The Hazardous Longitudinal Heterogeneity of Plaques: A Complex Mountain Range, Not a Single VolcanoPeter H Stone
The New England Journal of Medicine|October 22, 2004
Triggering myocardial infarctionPeter H Stone
Journal of the American College of Cardiology|November 13, 2007
C-reactive protein to identify early risk for development of calcific aortic stenosis: right marker? Wrong time?Peter H Stone
European Heart Journal|April 22, 2019
Evaluation of individual plaque risk based on plaque anatomic and biomechanical characteristics: methodologies and clinical applications are approaching an inflection pointPeter H Stone
JACC. Cardiovascular Imaging|August 4, 2022
Progressive Understanding of Coronary Microvascular Disease and Vasomotor Dysfunction: Some Answers, More QuestionsPeter H Stone
Journal of the American College of Cardiology|July 10, 2003
Early glycoprotein IIb/IIIa inhibitors in patients with non-ST-segment elevation myocardial infarction: are we ready to open the floodgates?Peter H Stone, Yerem Yeghiazarians
Circulation|November 9, 2016
In-Stent Atherosclerosis at a Crossroads: Neoatherosclerosis … or Paleoatherosclerosis?Ioannis Andreou, Peter H Stone
Current Treatment Options in Cardiovascular Medicine|January 17, 2002
ST-Segment Elevation Myocardial InfarctionYerem Yeghiazarians, Peter H. Stone
Pageof 21